Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
The Journal of Clinical Endocrinology & Metabolism · 21.01.2025 · 110 (Supplement_1) · S46-S55
DOI: 10.1210/clinem/dgae668 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 21.01.2025. Verfasst von David E Sandberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, Michigan Medicine, University of Michigan Medical Sch…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Mental Disorders, Mental Health. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Context
The goal of this review is to move beyond summarizing what is known about psychosexual development in females with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency—commonly studied as a natural experiment to understand prenatal androgen effects in 46,XX individuals. Instead, it will explore the various aspects of the condition that significantly impact the daily lives of both male and female patients and their families, with a particular focus on the implications for psychosocial, educational, and vocational adaptation. Evidence Acquisition This work represents a selective, yet balanced review of papers highlighting potential threats to positive psychological adaptation in both male and female individuals with CAH. Evidence Synthesis This review outlines the effects of both cross-cutting risks (such as challenges related to parenting and healthcare management) and CAH-specific risks (including growth and appearance changes, psychiatric and neurocognitive issues, reduced reproductive function and interest in parenting, and masculinization in girls and women) on psychosocial adaptation. Opportunities for optimizing psychological outcomes of those with CAH are presented.
Conclusion
Routine psychosocial screening of patient and family risk and resilience factors is recommended to identify areas of concern applicable to individual patients and families. Such screening should include assessment of both cross-cutting and condition-specific factors. This, in turn, provides a pathway forward for providing quality team-based patient-centered care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, Michigan Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Division of Pediatric Psychology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
ORCID-Profile: David E Sandberg, Melissa Gardner
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Sandberg, D. E., Gardner, M., & Lapham, Z. K. (2025). Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism, 110(Supplement_1), S46-S55. https://doi.org/10.1210/clinem/dgae668
Vancouver
Sandberg DE, Gardner M, Lapham ZK. Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism. 2025;110(Supplement_1):S46-S55. doi:10.1210/clinem/dgae668
BibTeX
@article{Sandberg2025,
author = {Sandberg, David E and Gardner, Melissa and Lapham, Zoe K},
title = {Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {Supplement_1},
pages = {S46--S55},
doi = {10.1210/clinem/dgae668}
}
EUVIMED